References

1. Hovland V, Riiser A, Mowinckel P, Carlsen KH, Lødrup Carlsen KC (2013) The significance of early recurrent wheeze for asthma outcomes in late childhood. Eur Respir J 41: 838-845 [CrossRef] [Google Scholar] [PubMed]
2. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, et al. (1995) Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332: 133-138 [CrossRef] [Google Scholar] [PubMed]
3. Liao O, Morphew T, Amaro S, Galant SP (2006) The Breathmobile: a novel comprehensive school-based mobile asthma care clinic for urban underprivileged children. J Sch Health 76: 313-319 [CrossRef] [Google Scholar] [PubMed]
4. Saglani S, Wilson N, Bush A (2007) Should preschool wheezers ever be treated with inhaled corticosteroids? Semin Respir Crit Care Med 28: 272- 285 [CrossRef] [Google Scholar] [PubMed]
5. Castro-Rodriguez JA, Rodrigo GJ (2009) Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 123: e519-525 [CrossRef] [Google Scholar] [PubMed]
6. Martinez FD (2002) Development of wheezing disorders and asthma in preschool children. Pediatrics 109: 362-367. [Google Scholar] [PubMed]
7. Global Initiative for Asthma: global strategy for the diagnosis and management of asthma in children 5 years and younger [Internet]. 2009
8. British Thoracic Society; Scottish Intercollegiate Guidelines Network (2014) British guideline on the management of asthma. Thorax 69 Suppl 1: 1-192 [Google Scholar] [PubMed]
9. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, et al. (2006) Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354: 1985-1997 [CrossRef] [Google Scholar] [PubMed]
10. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A, et al. (2006) Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy Infants (IFWIN): double-blind, randomized, controlled study. Lancet 368: 754-762 [CrossRef] [Google Scholar] [PubMed]
11. Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, et al. (2012) Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 367: 904-912 [CrossRef] [Google Scholar] [PubMed]
12. Kieninger E, Fuchs O, Latzin P, Frey U, Regamey N (2013) Rhinovirus infections in infancy and early childhood. Eur Respir J 41: 443-452. [CrossRef] [Google Scholar] [PubMed]
13. Takeyama A, Hashimoto K, Sato M, Sato T, Tomita Y, et al. (2014) Clinical and epidemiologic factors related to subsequent wheezing after virusinduced lower respiratory tract infections in hospitalized pediatric patients younger than 3 years. Eur J Pediatr 173: 959-966 [CrossRef] [Google Scholar] [PubMed]
14. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC 2nd, et al. (1999) Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 103: 630-636 [CrossRef] [Google Scholar] [PubMed]
15. Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL (1988) The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 24: 504-507 [CrossRef] [Google Scholar] [PubMed]
16. Yasui K, Kanda H, Iwanami T, Komiyama A (2003) Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation. Eur Respir J 22: 739-742 [CrossRef] [Google Scholar] [PubMed]
17. Yasui K, Kobayashi N, Yamazaki T, Koike K, Fukushima K, et al. (2005) Neutrophilic inflammation in childhood bronchial asthma. Thorax 60: 704- 705 [CrossRef] [Google Scholar] [PubMed]
18. Yilmaz O, Bakirtas A, Ertoy Karagol HI, Topal E, Demirsoy MS (2014) Allergic rhinitis may impact the recovery of pulmonary function tests after moderate/severe asthma exacerbation in children. Allergy 69: 652-657 [CrossRef] [Google Scholar] [PubMed]
19. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, et al. (2005) Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 171: 315-322 [CrossRef] [Google Scholar] [PubMed]
20. Okubo K, Baba K (2008) A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis. Allergol Int57: 383-390 [CrossRef] [Google Scholar] [PubMed]
21. Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, et al. (2008) Study of montelukast for the treatment of respiratory symptoms of postrespiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med 178: 854-860 [CrossRef] [Google Scholar] [PubMed]
22. Vlastos I, Athanasopoulos I, Mastronikolis NS, Panogeorgou T, Margaritis V, et al. (2009) Impaired mucociliary clearance in allergic rhinitis patients is related to a predisposition to rhinosinusitis. Ear Nose Throat J 88: E17-19 [Google Scholar] [PubMed]
23. Yasuda H, Yamaya M, Sasaki T, Inoue D, Nakayama K, et al. (2006) Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells. Eur Respir J 28: 51-58 [CrossRef] [Google Scholar] [PubMed]
24. Nakamura Y, Hoshino M, Sim JJ, Ishii K, Hosaka K, et al. (1998) Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 53: 835-841 [CrossRef] [Google Scholar] [PubMed]
25. Stelmach I, Jerzynska J, Kuna P (2002) A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol 109: 257-263 [CrossRef] [Google Scholar] [PubMed]
26. Wilson NW, Hogan MB, Harper CB, Peele K, Budhecha S, et al. (2012) Sinusitis and chronic cough in children. J Asthma Allergy 5: 27-32 [CrossRef] [Google Scholar] [PubMed]
27. Grossman J (1997) One airway, one disease. Chest 111: 11S-16S [CrossRef] [Google Scholar] [PubMed]